Xanadu Quantum Technologies Ltd. (NASDAQ/TSX: XNDU) has announced its financial results for the second quarter ended June 30, 2026. The Toronto-based photonic quantum leader highlighted significant hardware and algorithmic progress, expansion of its U.S. operations, and strategic use of its synthetic at-the-market (ATM) equity facility to fortify its balance sheet.

Because of the reverse recapitalization resulting from its Q1 2026 SPAC merger, historical share counts and per-share metrics have been retroactively recast. The table below summarizes key GAAP financial metrics for Q2 2026 compared with the prior quarter (Q1 2026) and the year-ago quarter (Q2 2025).

Amounts in $MQ2’2026Q1’2026Q2’2025% vs Q1’2026% vs Q2’2025
Revenue$1.51$2.83$1.06-46.6%+42.5%
Operating Expenses$31.50$26.10$16.58+20.7%+90.0%
Operating Loss($29.99)($23.27)($15.52)+28.9%+93.2%
Net Loss($42.05)($20.60)($15.14)+104.1%+177.7%
Cash and Cash Equivalents$312.78$272.47$16.16*+14.8%+1,835.5%

*Note: Q2 2025 cash balance reflects the pre-merger private entity baseline.

Financial Results and ATM Equity Facility Utilization

Xanadu ended the second quarter in a strong liquidity position with $312.8 million in cash and cash equivalents, up from $272.5 million at the end of Q1 2026. This increase was primarily driven by the disciplined utilization of its $300 million Standby Equity Purchase Agreement (synthetic ATM facility) established with Yorkville Advisors in May 2026. During Q2, the company raised $67.2 million in net proceeds by issuing 5.5 million Class B subordinate voting shares at an average net price of $12.28 per share.

Second-quarter revenue was $1.51 million, representing a 42.5% increase year-over-year compared to $1.06 million in Q2 2025 (primarily driven by DARPA Stage B contract revenue), though down sequentially from $2.83 million in Q1 2026.

GAAP Net Loss for Q2 2026 expanded to ($42.05) million, or ($0.14) per basic and diluted share, compared to ($20.60) million in Q1 2026 and ($15.14) million in Q2 2025. The widening loss was driven by increased R&D engineering hires ($19.72M vs $17.35M in Q1), higher G&A public company costs ($11.05M), and a $10.60 million non-cash loss on the fair value remeasurement of earn-out share liabilities. On a non-GAAP basis, Adjusted EBITDA loss was ($21.33) million.

Capital expenditures for the quarter rose sharply to $6.4 million (up from $0.3M in Q1 2026), reflecting increased investments in foundry fabrication runs and laboratory infrastructure.

Hardware and Fabrication Breakthroughs

Software, Algorithms, and Ecosystem Momentum

Resources and Further Reading

Additional information regarding this report can be found in the Xanadu Q2 2026 press release here.

August 6, 2026